Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1518497

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1518497

Cough Remedies Market Size - By Medication Type (Antihistamines, Antibiotics, Bronchodilators, Decongestants, Expectorants), Dosage Form (Oral Syrups, Tablets/Pills, Nasal Drop, Lozenges), Age Group, Distribution Channel & Forecast, 2024 - 2032

PUBLISHED:
PAGES: 110 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 5350
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

Cough Remedies Market size is projected to record 5.6% CAGR from 2024 to 2032, driven by stringent government approvals to ensure safety standards. Regulatory agencies are assessing their effectiveness and potential side effects due to rising scrutiny as authorities are refining safety protocols and reviewing new formulations.

Researchers and manufacturers are exploring innovative ingredients and formulations that comply with evolving regulatory requirements. The strong focus on enhancing efficacy while minimizing risks for ensuring that cough remedies remain safe and reliable for public use will drive the industry growth. For instance, in December 2023, the Drugs Controller General of India (DCGI) initiated a nationwide drive for ensuring global quality standards in cough syrup manufacturing. This effort is enhancing safety and efficacy standards for cough remedies across the country.

The overall market is segregated into medication type, dosage form, age group, distribution channel, and region.

In terms of medication type, the cough remedies market from the antihistamines segment is expected to record significant CAGR from 2024 to 2032. Antihistamines are widely utilized to alleviate allergic reactions by blocking histamine receptors in the body. They are also researched for their potential in treating various allergic conditions and symptoms. Rising efforts for providing more targeted and efficient relief for individuals affected by allergies while ensuring improved quality of life and better management of allergic reactions will favor the segment growth.

By distribution channel, the cough remedies industry from the online pharmacy segment is projected to rise from 2024 to 2032, driven by their ability of transforming access to medications by providing convenient digital platforms for purchasing and delivering healthcare products. Online channels are expanding their services to offer a wide range of prescription and over-the-counter medications, as well as health-related products. They are also integrating telemedicine services to improve user interface as well as enhance the overall customer experience.

Regionally, the Asia Pacific cough remedies market size is projected to exhibit robust growth between 2024 and 2032, fueled by the rise in advertising and promotional campaigns, along with changing lifestyles. As urbanization and lifestyles are evolving in the region, there are ongoing efforts to tailor marketing strategies to urban dwellers. This adaptation involves utilizing digital platforms more extensively and crafting targeted messages to resonate with urban consumers seeking convenient and effective solutions for managing respiratory health in the region.

Product Code: 9224

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increase in prevalence of respiratory diseases
      • 3.2.1.2 Rise in awareness levels and demand for over-the-counter (OTC) products
      • 3.2.1.3 Surging geriatric population
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Side effects associated with cough medications
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Pipeline analysis
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis
  • 3.8 Future market trends

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Medication Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Antihistamines
  • 5.3 Antibiotics
  • 5.4 Bronchodilators
  • 5.5 Decongestants
  • 5.6 Expectorants

Chapter 6 Market Estimates and Forecast, By Dosage Form, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Oral syrups
  • 6.3 Tablets/Pills
  • 6.4 Nasal drop
  • 6.5 Lozenges

Chapter 7 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Adult
  • 7.3 Pediatric

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Retail pharmacy
  • 8.3 Hospital pharmacy
  • 8.4 Online pharmacy
  • 8.5 Other distribution channels

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 AstraZeneca plc
  • 10.2 Bayer AG
  • 10.3 GSK plc
  • 10.4 Johnson & Johnson
  • 10.5 Novartis AG
  • 10.6 Pfizer Inc.
  • 10.7 Prestige Consumer Healthcare
  • 10.8 Procter & Gamble
  • 10.9 Reckitt Benckiser Group plc
  • 10.10 Sun Pharmaceutical Industries Ltd
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!